• 

  Functional diversity and co-operativity between subclonal populations of paediatric glioblastoma and diffuse intrinsic pontine glioma cells 

  Jones, C
• 

  Synergistic antitumour effects of rapamycin and oncolytic reovirus. 

  Comins, C; Simpson, GR; Rogers, W; Relph, K; Harrington, K; Melcher, A; Roulstone, V; Kyula, J; Pandha, H (2018-05-03)

  There are currently numerous oncolytic viruses undergoing clinical trial evaluation in cancer patients and one agent, Talimogene laherparepvec, has been approved for the treatment of malignant melanoma. This progress ...
• 

  Genome-wide association analysis identifies a meningioma risk locus at 11p15.5 

  Cornish, A; Claus, E; Broderick, P; Schildkraut, J; Houlston, R; Wiemels, J
• 

  E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium. 

  Horne, HN; Oh, H; Sherman, ME; Palakal, M; Hewitt, SM; Schmidt, MK; Milne, RL; Hardisson, D; Benitez, J; Blomqvist, C; Bolla, MK; Brenner, H; Chang-Claude, J; Cora, R; Couch, FJ; Cuk, K; Devilee, P; Easton, DF; Eccles, DM; Eilber, U; Hartikainen, JM; Heikkilä, P; Holleczek, B; Hooning, MJ; Jones, M; Keeman, R; Mannermaa, A; Martens, JWM; Muranen, TA; Nevanlinna, H; Olson, JE; Orr, N; Perez, JIA; Pharoah, PDP; Ruddy, KJ; Saum, K-U; Schoemaker, MJ; Seynaeve, C; Sironen, R; Smit, VTHBM; Swerdlow, AJ; Tengström, M; Thomas, AS; Timmermans, AM; Tollenaar, RAEM; Troester, MA; van Asperen, CJ; van Deurzen, CHM; Van Leeuwen, FF; Van't Veer, LJ; García-Closas, M; Figueroa, JD (2018-04-26)

  E-cadherin (CDH1) is a putative tumor suppressor gene implicated in breast carcinogenesis. Yet, whether risk factors or survival differ by E-cadherin tumor expression is unclear. We evaluated E-cadherin tumor immunohistochemistry ...
• 

  Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the International and European Society for Pediatric Oncology DIPG Registries. 

  Hoffman, LM; Veldhuijzen van Zanten, SEM; Colditz, N; Baugh, J; Chaney, B; Hoffmann, M; Lane, A; Fuller, C; Miles, L; Hawkins, C; Bartels, U; Bouffet, E; Goldman, S; Leary, S; Foreman, NK; Packer, R; Warren, KE; Broniscer, A; Kieran, MW; Minturn, J; Comito, M; Broxson, E; Shih, C-S; Khatua, S; Chintagumpala, M; Carret, AS; Escorza, NY; Hassall, T; Ziegler, DS; Gottardo, N; Dholaria, H; Doughman, R; Benesch, M; Drissi, R; Nazarian, J; Jabado, N; Boddaert, N; Varlet, P; Giraud, G; Castel, D; Puget, S; Jones, C; Hulleman, E; Modena, P; Giagnacovo, M; Antonelli, M; Pietsch, T; Gielen, GH; Jones, DTW; Sturm, D; Pfister, SM; Gerber, NU; Grotzer, MA; Pfaff, E; von Bueren, AO; Hargrave, D; Solanki, GA; Jadrijevic Cvrlje, F; Kaspers, GJL; Vandertop, WP; Grill, J; Bailey, S; Biassoni, V; Massimino, M; Calmon, R; Sanchez, E; Bison, B; Warmuth-Metz, M; Leach, J; Jones, B; van Vuurden, DG; Kramm, CM; Fouladi, M (2018-05-10)

  Purpose Diffuse intrinsic pontine glioma (DIPG) is a brainstem malignancy with a median survival of < 1 year. The International and European Society for Pediatric Oncology DIPG Registries collaborated to compare clinical, ...

View more